Medico Remedies Other Announcement
Medico Remedies appointed V. J. Talati & Co as cost auditor for 12 months. The appointment is an outcome of a board meeting held November 9, 2026.
- Execution
- 12 months
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Medico Remedies appointed V. J. Talati & Co as cost auditor for 12 months. The appointment is an outcome of a board meeting held November 9, 2026.
Medico Remedies Ltd reported revenue from operations of ₹74 Cr (+40.7% YoY) and net profit of ₹2.4 Cr (-7.7% YoY) for Q2 FY27.
Medico Remedies gave advance notice of a 9 November 2026 board meeting to consider unaudited standalone results for the quarter ended September 2026. The trading window is closed from 1 October to 12 November 2026.
Medico Remedies Ltd has filed its quarterly shareholding pattern statement for the period ended September 30, 2026. This is a periodic regulatory compliance filing.